Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF MENTAL HEALTH |
|---|---|
| Recipient Organization | Oui Therapeutics, Inc |
| Country | United States |
| Start Date | Feb 15, 2021 |
| End Date | Mar 31, 2024 |
| Duration | 1,140 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10601611 |
ABSTRACT Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized
controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will contribute to our understanding of the use of mobile technology as a suicide prevention tool.
Oui Therapeutics, Inc
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant